Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $4.94 million. The enterprise value is $33.19 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 2.17 million shares outstanding. The number of shares has increased by 26.38% in one year.
| Current Share Class | 2.17M |
| Shares Outstanding | 2.17M |
| Shares Change (YoY) | +26.38% |
| Shares Change (QoQ) | +61.94% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | 2.17% |
| Float | 1.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.28 |
| Forward PS | 0.30 |
| PB Ratio | 0.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 4.44.
| Current Ratio | 0.95 |
| Quick Ratio | 0.12 |
| Debt / Equity | 4.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -319.25% and return on invested capital (ROIC) is -45.30%.
| Return on Equity (ROE) | -319.25% |
| Return on Assets (ROA) | -37.42% |
| Return on Invested Capital (ROIC) | -45.30% |
| Return on Capital Employed (ROCE) | -172.43% |
| Revenue Per Employee | $241,020 |
| Profits Per Employee | -$829,490 |
| Employee Count | 49 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.97% in the last 52 weeks. The beta is 0.61, so Jaguar Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -92.97% |
| 50-Day Moving Average | 2.01 |
| 200-Day Moving Average | 8.75 |
| Relative Strength Index (RSI) | 58.90 |
| Average Volume (20 Days) | 176,708 |
Short Selling Information
The latest short interest is 36,502, so 1.68% of the outstanding shares have been sold short.
| Short Interest | 36,502 |
| Short Previous Month | 66,131 |
| Short % of Shares Out | 1.68% |
| Short % of Float | 2.40% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $11.81 million and -$40.65 million in losses. Loss per share was -$26.56.
| Revenue | 11.81M |
| Gross Profit | 9.67M |
| Operating Income | -32.85M |
| Pretax Income | -41.41M |
| Net Income | -40.65M |
| EBITDA | -30.94M |
| EBIT | -32.85M |
| Loss Per Share | -$26.56 |
Full Income StatementBalance Sheet
The company has $2.21 million in cash and $30.53 million in debt, giving a net cash position of -$28.32 million or -$13.02 per share.
| Cash & Cash Equivalents | 2.21M |
| Total Debt | 30.53M |
| Net Cash | -28.32M |
| Net Cash Per Share | -$13.02 |
| Equity (Book Value) | 6.88M |
| Book Value Per Share | 3.60 |
| Working Capital | -1.32M |
Full Balance SheetCash Flow
| Operating Cash Flow | -27.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -27.68M |
| FCF Per Share | -$12.73 |
Full Cash Flow StatementMargins
| Gross Margin | 81.88% |
| Operating Margin | -278.13% |
| Pretax Margin | -350.64% |
| Profit Margin | n/a |
| EBITDA Margin | -261.96% |
| EBIT Margin | -278.13% |
| FCF Margin | n/a |
Dividends & Yields
Jaguar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.38% |
| Shareholder Yield | -26.38% |
| Earnings Yield | -834.32% |
| FCF Yield | -568.10% |
Analyst Forecast
The average price target for Jaguar Health is $60.00, which is 2,543.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.00 |
| Price Target Difference | 2,543.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
Jaguar Health has an Altman Z-Score of -12.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.55 |
| Piotroski F-Score | 4 |
